World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
109
Citations
49009
World Ranking
997
National Ranking
606

Medicine

D-Index
115
Citations
52407
World Ranking
4516
National Ranking
2456

Overview

David Venzon is affiliated with the National Institutes of Health in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions to the subfields of Immunology, Infectious Diseases, Molecular Biology, Neurology, and Epidemiology.

The scientist has explored a diverse range of topics including HIV Research and Treatment, Immune Cell Function and Interaction, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Neuroblastoma Research and Treatments, Hematopoietic Stem Cell Transplantation, and Immunotherapy and Immune Responses.

David Venzon has published extensively in notable venues. Frequent publication venues include:

  • PLoS Pathogens
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Journal of Virology
  • Neuro-Oncology

Recent influential papers by Venzon include:

  • "Selumetinib in Children with Inoperable Plexiform Neurofibromas" (2020), published in New England Journal of Medicine
  • "Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas" (2023), published in Neuro-Oncology
  • "Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy" (2021), published in European Urology
  • "Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques" (2021), published in JCI Insight
  • "Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge" (2020), published in Cell Reports

They have collaborated extensively with several frequent co-authors, including:

  • David C. Montefiori
  • Mohammad Arif Rahman
  • Massimiliano Bissa
  • Genoveffa Franchini
  • Melvin N. Doster

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.

    Austin G. Duffy;Susanna V. Ulahannan;Oxana Makorova-Rusher;Osama Rahma

  • Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.

    I. Magrath;M. Adde;Aziza Shad;D. Venzon

  • Surgery to cure the Zollinger-Ellison syndrome.

    J A Norton;D L Fraker;H R Alexander;D J Venzon

  • Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study

    F Gibril;J C Reynolds;J L Doppman;C C Chen

  • Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

    Mario Clerici;Frances T. Hakim;David J. Venzon;Stephen Blatt

  • Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

    Claude Sportès;Frances T. Hakim;Sarfraz A. Memon;Hua Zhang

  • Determinants of Metastatic Rate and Survival in Patients With Zollinger-Ellison Syndrome: A Prospective Long-term Study

    H.Christian Weber;David J. Venzon;Jaw-Town Lin;Vitaly A. Fishbein

  • Selumetinib in Children with Inoperable Plexiform Neurofibromas

    Andrea M. Gross;Pamela L. Wolters;Eva Dombi;Andrea Baldwin

  • Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer

    Alain Thibault;Dvorit Samid;Dvorit Samid;Anne C. Tompkins;William D. Figg

  • Zollinger-Ellison syndrome. Clinical presentation in 261 patients.

    Praveen K. Roy;David J. Venzon;Houmayoun Shojamanesh;Alaa Abou-Saif

  • Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome

    Fang Yu;David J. Venzon;Jose Serrano;Stephan U. Goebel

  • A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.

    H R Alexander;G M Doherty;C M Buresh;D J Venzon

  • Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251.

    V. Raúl Gómez-Román;L. Jean Patterson;David Venzon;David Liewehr

  • Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

    Maryalice Stetler-Stevenson;Diane C. Arthur;Nicholas Jabbour;Xiu Y. Xie

  • Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas

    Zhengping Zhuang;Alexander O. Vortmeyer;Svetlana Pack;Steve Huang

  • Cytokine Production Patterns in Cervical Intraepithelial Neoplasia: Association With Human Papillomavirus Infection

    M. Clerici;Marcello Merola;E. Ferrario;D. Trabattoni

  • ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

    R. Pal;D. Venzon;N. L. Letvin;S. Santra

  • Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

    Charles B. Foster;Thomas Lehrnbecher;Femke Mol;Seth M. Steinberg

  • CLINICAL AND GENETIC CHARACTERIZATION OF PHEOCHROMOCYTOMA IN VON HIPPEL-LINDAU FAMILIES: COMPARISON WITH SPORADIC PHEOCHROMOCYTOMA GIVES INSIGHT INTO NATURAL HISTORY OF PHEOCHROMOCYTOMA

    McCLELLAN M. Walther;Robert Reiter;Harry R. Keiser;Peter L. Choyke

Frequent Co-Authors

Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
William D. Figg
William D. Figg National Institutes of Health
David C. Montefiori
David C. Montefiori Duke University
Robert T. Jensen
Robert T. Jensen National Institutes of Health
Vaniambadi S. Kalyanaraman
Vaniambadi S. Kalyanaraman North Shore University Hospital
George N. Pavlakis
George N. Pavlakis Emory University
Philip A. Pizzo
Philip A. Pizzo Stanford University
Jeffrey A. Norton
Jeffrey A. Norton Stanford University
Georgia D. Tomaras
Georgia D. Tomaras Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to a wide range of online degrees and career options, especially in healthcare and life sciences. Many students look into online rn to bsn programs to build on their scientific foundation and advance in nursing roles. These flexible options are ideal for those with busy schedules who want to upskill efficiently.

Leadership positions often require advanced degrees, making online masters healthcare management a popular choice. This pathway suits students interested in administration and policy aspects of the healthcare industry.

Mental health is an expanding field, and biochemistry graduates with an interest in psychology may consider fast track mental health nursing. These programs focus on clinical care for those facing mental health challenges.

For students fascinated by metabolic processes and wellness, nutrition degree programs can lead to careers in dietetics, research, or public health. Each of these online pathways leverages your biology or biochemistry expertise into meaningful, high-demand professions.

Best Scientists Citing David Venzon

Trending Scientists

Recently Published Articles